Volkmann, E. R., Andréasson, K. & Smith, V. Systemic sclerosis. Lancet 401, 304–318 (2023).

Article  PubMed  Google Scholar 

Denton, C. P., Wells, A. U. & Coghlan, J. G. Major lung complications of systemic sclerosis. Nat. Rev. Rheumatol. 14, 511–527 (2018).

Article  PubMed  Google Scholar 

Elhai, M. et al. Mapping and predicting mortality from systemic sclerosis. Ann. Rheum. Dis. 76, 1897–1905 (2017).

Article  PubMed  Google Scholar 

Perelas, A., Silver, R. M., Arrossi, A. V. & Highland, K. B. Systemic sclerosis-associated interstitial lung disease. Lancet Respir. Med. 8, 304–320 (2020).

Article  CAS  PubMed  Google Scholar 

Giacomelli, R. et al. Interstitial lung disease in systemic sclerosis: current and future treatment. Rheumatol. Int. 37, 853–863 (2017).

Article  PubMed  Google Scholar 

Wijsenbeek, M., Suzuki, A. & Maher, T. M. Interstitial lung diseases. Lancet 400, 769–786 (2022).

Article  PubMed  Google Scholar 

Cabral-Marques, O. & Riemekasten, G. Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis. Autoimmun. Rev. 15, 690–694 (2016).

Article  CAS  PubMed  Google Scholar 

Di Benedetto, P. et al. Endothelial-to-mesenchymal transition in systemic sclerosis. Clin. Exp. Immunol. 205, 12–27 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Li, Z. & Jimenez, S. A. Protein kinase Cδ and c-Abl kinase are required for transforming growth factor β induction of endothelial-mesenchymal transition in vitro. Arthritis Rheum. 63, 2473–2483 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wermuth, P. J., Li, Z., Mendoza, F. A. & Jimenez, S. A. Stimulation of transforming growth factor-β1-induced endothelial-to-mesenchymal transition and tissue fibrosis by endothelin-1 (ET-1): a novel profibrotic effect of ET-1. PLoS One 11, e0161988 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Ludwicka‐Bradley, A., Silver, R. M. & Bogatkevich, G. S. Coagulation and autoimmunity in scleroderma interstitial lung disease. Semin. Arthritis Rheum. 41, 212–222 (2011).

Article  PubMed  Google Scholar 

Dowson, C., Simpson, N., Duffy, L. & O’Reilly, S. Innate immunity in systemic sclerosis. Curr. Rheumatol. Rep. 19, 2 (2017).

Article  PubMed  Google Scholar 

Ryu, C. et al. Bioactive plasma mitochondrial DNA is associated with disease progression in scleroderma-associated interstitial lung disease. Arthritis Rheumatol. 72, 1905–1915 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reyfman, P. A. et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 199, 1517–1536 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Renzoni, E. A., Poletti, V. & Mackintosh, J. A. Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia? Lancet 398, 1437–1449 (2021).

Article  CAS  PubMed  Google Scholar 

Pechkovsky, D. V. et al. Alternatively activated alveolar macrophages in pulmonary fibrosis — mediator production and intracellular signal transduction. Clin. Immunol. 137, 89–101 (2010).

Article  CAS  PubMed  Google Scholar 

Trombetta, A. C. et al. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. Respir. Res. 19, 186 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Valenzi, E. et al. Disparate interferon signaling and shared aberrant basaloid cells in single-cell profiling of idiopathic pulmonary fibrosis and systemic sclerosis-associated interstitial lung disease. Front. Immunol. 12, 595811 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liossis, S. C. & Staveri, C. The role of B cells in scleroderma lung disease pathogenesis. Front. Med. 9, 936182 (2022).

Article  Google Scholar 

Aravena, O. et al. TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients. Arthritis Res. Ther. 19, 8 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Higashioka, K. et al. Generation of a novel CD30+ B cell subset producing GM-CSF and its possible link to the pathogenesis of systemic sclerosis. Clin. Exp. Immunol. 201, 233–243 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

François, A. et al. B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis. Arthritis Res. Ther. 15, R168 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Dumoitier, N. et al. Scleroderma peripheral B lymphocytes secrete Interleukin-6 and transforming growth factor β and activate fibroblasts. Arthritis Rheumatol. 69, 1078–1089 (2017).

Article  CAS  PubMed  Google Scholar 

Fava, A. et al. Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in scleroderma. Arthritis Res. Ther. 18, 99 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Luzina, I. G. et al. Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients. Arthritis Rheum. 48, 2262–2274 (2003).

Article  CAS  PubMed  Google Scholar 

Ramahi, A., Altorok, N. & Kahaleh, B. Epigenetics and systemic sclerosis: an answer to disease onset and evolution? Eur. J. Rheumatol. 7, S147–S156 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Orvain, C., Assassi, S., Avouac, J. & Allanore, Y. Systemic sclerosis pathogenesis: contribution of recent advances in genetics. Curr. Opin. Rheumatol. 32, 505–514 (2020).

Article  CAS  PubMed  Google Scholar 

Feghali-Bostwick, C., Medsger, T. A. Jr & Wright, T. M. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum. 48, 1956–1963 (2003).

Article  PubMed  Google Scholar 

Ramos, P. S. et al. Integrative analysis of DNA methylation in discordant twins unveils distinct architectures of systemic sclerosis subsets. Clin. Epigenetics. 11, 58 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Rubio-Rivas, M., Moreno, R. & Corbella, X. Occupational and environmental scleroderma. Systematic review and meta-analysis. Clin. Rheumatol. 36, 569–582 (2017).

Article  PubMed  Google Scholar 

Boesch, M. et al. Transcriptomic profiling reveals disease-specific characteristics of epithelial cells in idiopathic pulmonary fibrosis. Respir. Res. 21, 165 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

DeMizio, D. J. & Bernstein, E. J. Detection and classification of systemic sclerosis-related interstitial lung disease: a review. Curr. Opin. Rheumatol. 31, 553–560 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

van den Hoogen, F. et al. 2013 Classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 65, 2737–2747 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Hoffmann-Vold, A. M. et al. Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort. Am. J. Respir. Crit. Care Med. 200, 1258–1266 (2019).

Article  PubMed  Google Scholar 

Hoffmann-Vold, A. M. et al. The need for a holistic approach for SSc-ILD — achievements and ambiguity in a devastating disease. Respir. Res. 21, 197 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Bernstein, E. J. et al. Performance characteristics of pulmonary function tests for the detection of interstitial lung disease in adults with early diffuse cutaneous systemic sclerosis. Arthritis Rheumatol. 72, 1892–1896 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frauenfelder, T. et al. Screening for interstitial lung disease in systemic sclerosis: performance of high-resolution CT with limited number of slices: a prospective study. Ann. Rheum. Dis. 73, 2069–2073 (2014).

Article  PubMed  Google Scholar 

Kowal-Bielecka, O. et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann. Rheum. Dis. 76, 1327–1339 (2017).